The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

Although cytogenetic abnormalities are important prognostic factors in myeloid malignancies, they are not included in current prognostic scores for primary myelofibrosis (PMF). To determine their relevance in PMF, we retrospectively examined the impact of cytogenetic abnormalities and karyotypic evo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood
Hlavní autoři: Tam, Constantine S., Abruzzo, Lynne V., Lin, Katherine I., Cortes, Jorge, Lynn, Alice, Keating, Michael J., Thomas, Deborah A., Pierce, Sherry, Kantarjian, Hagop, Verstovsek, Srdan
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2009
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828077/
https://ncbi.nlm.nih.gov/pubmed/19131547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-09-178541
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky